Table 3.

Clinical outcomes after initial therapy and at final follow-up for each risk of recurrence categories in the whole cohort

	Number	Percentage
Initial response to treatment
Low risk	146
Excellent	81	55.5
Indeterminate	37	25.3
BIR	15	10.3
SIR	13	8.9
Intermediate risk	64
Excellent	17	26.6
Indeterminate	20	31.2
BIR	13	20.3
SIR	14	21.9
High risk	58
Excellent	2	3.4
Indeterminate	4	6.8
BIR	7	12.2
SIR	45	77.6
Status at final follow-up
Low risk	146
NED	109	74.7
Indeterminate	26	17.8
BIR	8	5.5
SIR	3	2.0
Intermediate risk	64
NED	29	45.3
Indeterminate	20	31.2
BIR	5	7.8
SIR	10	15.6
High risk	58
NED	6	10.3
Indeterminate	8	13.8
BIR	11	18.9
SIR	33	56.9

NED, no evidence of disease; BIR, biochemical incomplete response; SIR, structural incomplete response.